XW033R9Introduction of Rezafungin into Peripheral Vein, Percutaneous Approach, New Technology Group 9

New Technology›Anatomical Regions›Introduction
  • Billable / Specific Code
ICD-10-PCS XW033R9
CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.FacebookXLinkedInPrint

XW033R9 is a billable ICD-10-PCS procedure code for Introduction of Rezafungin into Peripheral Vein, Percutaneous Approach, New Technology Group 9. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Administration of therapeutic substances, NEC.

Code Identity

ICD-10-PCS Code
XW033R9
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Rezafungin into Peripheral Vein, Percutaneous Approach, New Technology Group 9
Short Description
Introduce Rezafungin in Periph Vein, Perc, New Tech 9
Parent Code
XW0

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemWAnatomical Regions
3Operation0Introduction
4BodyPart3Peripheral Vein
5Approach3Percutaneous
6Device/Substance/TechnologyRRezafungin
7Qualifier9New Technology Group 9

In the ICD-10-PCS Alphabetic Index

These FY 2027 ICD-10-PCS Alphabetic Index entries lead to this code:

Iloprost
Leads to this code's table
Sarilumab
Leads to this code's table
Posoleucel
Leads to this code's table
Rezafungin
Leads to this code's table
Treosulfan
Leads to this code's table
Baricitinib
Leads to this code's table
Sabizabulin
Leads to this code's table
Tocilizumab
Leads to this code's table
Caplacizumab
Leads to this code's table
COVID-19 Vaccine
Leads to this code's table
Inebilizumab-cdon
Leads to this code's table
Sulbactam-Durlobactam
Leads to this code's table
CD24Fc Immunomodulator
Leads to this code's table
COVID-19 Vaccine Dose 1
Leads to this code's table
COVID-19 Vaccine Dose 2
Leads to this code's table

Browse the full ICD-10-PCS Alphabetic Index →

Clinical Classification (CCSR)

AHRQ groups this procedure code into these clinical categories.

ADM021
Administration of therapeutic substances, NEC
Clinical domain: Administration of Therapeutic Substances

Code History

Replaces previously assigned code(s):
  • 3E03329 — Introduce of Oth Anti-infect into Periph Vein, Perc Approach

Similar Procedure Codes

Questions About XW033R9

Is XW033R9 a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Rezafungin into Peripheral Vein, Percutaneous Approach, New Technology Group 9 on inpatient claims from October 1, 2026 through September 30, 2027.

What do the characters in XW033R9 mean?

The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character 3 is the BodyPart (Peripheral Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character R is the Device/Substance/Technology (Rezafungin); the 7th character 9 is the Qualifier (New Technology Group 9).